The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Fanucci Marsha since year 2005.
The trader's CIK number is 1298814.
At the time of the last reporting, Fanucci Marsha was the Director of Alnylam Pharmaceuticals, Inc. .
(stock ticker symbol ALNY).
See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-11-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 75,000 | 14.96 | 1,122,375 |
| 2019-11-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 75,000 | 100.00 | 7,500,000 |
| 2015-03-18 | IRWD | Ironwood Pharmaceuticals Inc | Sale | 31,339 | 15.68 | 491,395 |
| 2013-03-15 | MNTA | Momenta Pharmaceuticals Inc | Sale | 29,400 | 14.15 | 416,010 |
| 2012-02-21 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 10,000 | 10.75 | 107,500 |
| 2010-02-02 | IRWD | Ironwood Pharmaceuticals Inc | Buy | 22,000 | 11.25 | 247,500 |
| 2008-03-11 | MLNM | Millennium Pharmaceuticals Inc | Sale | 4,429 | 12.82 | 56,779 |
| 2008-03-07 | MLNM | Millennium Pharmaceuticals Inc | Sale | 5,989 | 13.34 | 79,887 |
| 2008-02-29 | MLNM | Millennium Pharmaceuticals Inc | Sale | 5,480 | 13.68 | 74,939 |
| 2007-09-18 | MLNM | Millennium Pharmaceuticals Inc | Sale | 10,064 | 10.58 | 106,477 |
| 2007-09-19 | MLNM | Millennium Pharmaceuticals Inc | Sale | 7,436 | 10.67 | 79,342 |
| 2007-03-08 | MLNM | Millennium Pharmaceuticals Inc | Sale | 6,173 | 10.41 | 64,260 |
| 2007-03-12 | MLNM | Millennium Pharmaceuticals Inc | Sale | 4,245 | 10.64 | 45,166 |
| 2007-02-06 | MLNM | Millennium Pharmaceuticals Inc | Sale | 7,497 | 11.17 | 83,741 |
| 2006-09-18 | MLNM | Millennium Pharmaceuticals Inc | Sale | 10,003 | 10.95 | 109,532 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fanucci Marsha (Director of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.